Engineers Gate Manager’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Engineers Gate Manager’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19,990	Closed	-$560K	–	2296
2025 Q2	$560K	Buy	+19,990	New	+$536K	0.01%	1425
2023 Q3	–	Sell	-5,574	Closed	-$227K	–	1905
2023 Q2	$227K	Buy	+5,574	New	+$227K	0.01%	1430
2020 Q3	–	Sell	-1,230	Closed	-$243K	–	1793
2020 Q2	$243K	Sell	1,230 -310	-20%	-$64.2K	0.01%	1331
2020 Q1	$302K	Buy	+1,540	New	+$331K	0.02%	1037

Other funds holding LKFT

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Engineers Gate Manager's LKFT Position: Q3 2025 in Review

Engineers Gate Manager sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2025, closing a stake of 19,990 shares — an estimated $560K sold.

Engineers Gate Manager first reported a position in LKFT in Q1 2020 and held it in 4 quarters. The position peaked at $560K in Q2 2025. 92 funds tracked by Wall St. Rank hold LKFT as of Q3 2025.

Engineers Gate Manager reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2025 after selling out during the quarter.
Engineers Gate Manager sold 19,990 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2025, an estimated $560K.
Engineers Gate Manager first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and held it in 4 quarters.
Engineers Gate Manager's Lakefront Biotherapeutics American Depositary Shares position peaked at $560K in Q2 2025.
92 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2025.

Based on Engineers Gate Manager's 13F filing for Q3 2025, filed 14 Nov 2025.